Anti-host isohemagglutinin production is associated with a higher risk of acute GVHD in ABO-incompatible transplantation

Bone Marrow Transplantation

Volumn 47, Issue 10, 2012, Pages 1356-1360

  Igarashi, A ^a   Kakihana, K ^a   Haraguchi, K ^a   Aoki, J ^a   Kobayashi, T ^a   Okuyama, Y ^a   Ohashi, K ^a   Sakamaki, H ^a  

^a TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

Author keywords

ABO incompatible transplantation; Acute GVHD; Isohemagglutinin

Indexed keywords

ANTIBODY; HLA A ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; ISOHEMAGGLUTININ ANTIBODY; UNCLASSIFIED DRUG;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ANTIBODY PRODUCTION; ANTIBODY TITER; APLASTIC ANEMIA; ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; MYELOFIBROSIS; OVERALL SURVIVAL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY;

ABO BLOOD-GROUP SYSTEM; ACUTE DISEASE; ADOLESCENT; ADULT; AGED; FEMALE; GRAFT VS HOST DISEASE; HEMAGGLUTININS; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; ISOANTIBODIES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84867396239     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2012.32     Document Type: Article

References (18)

1. Beatty PG, Clift RA, Mickelson EM, Nisperos BB, Flournoy N, Martin PJ et al. Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med 1985; 313: 765-771.
2. Cutler C, Giri S, Jeyapalan S, Paniagua D, Viswanathan A, Antin JH. Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis. J Clin Oncol 2001; 19: 3685-3691.
3. Goulmy E, Schipper R, Pool J, Blokland E, Falkenburg JH, Vossen J et al. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N Engl J Med 1996; 334: 281-285.
4. Weisdorf D, Hakke R, Blazar B, Miller W, McGlave P, Ramsay N et al. Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation. Transplantation 1991; 51: 1197-1203.
5. Kim JG, Sohn SK, Kim DH, Baek JH, Lee KB, Min WS et al. Impact of ABO incompatibility on outcome after allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant 2005; 35: 489-495.
6. Rozman P, Kosir A, Bohinjec M. Is the ABO incompatibility a risk factor in bone marrow transplantation? Transpl Immunol 2005; 14: 159-169.
7. Helming AM, Brand A, Wolterbeek R, van Tol MJ, Egeler RM, Ball LM. ABO incompatible stem cell transplantation in children does not influence outcome. Pediatr Blood Cancer 2007; 49: 313-317.
8. Wang Z, Sorror ML, Leisenring W, Schoch G, Maloney DG, Sandmaier BM et al. The impact of donor type and ABO incompatibility on transfusion requirements after nonmyeloablative haematopoietic cell transplantation. Br J Haematol 2010; 149: 101-110.
9. Chung HJ, Lee JH, Kwon SW. Significance of donor-derived isoagglutinins in ABO-Incompatible hematopoietic stem cell transplantation. J Clin Lab Anal 2008; 22: 383-390.
10. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995; 15: 825-828.
11. Michonneau D, Peffault de Latour R, Porcher R, Robin M, Benbunan M, Rocha V et al. Influence of bone marrow graft B lymphocyte subsets on outcome after HLA-identical sibling transplants. Br J Haematol 2009; 145: 107-114.
12. Iori AP, Torelli GF, De Propris MS, Milano F, Pupella S, Gozzer M et al. B-cell concentration in the apheretic product predicts acute graft-versus-host disease and treatment-related mortality of allogeneic peripheral blood stem cell transplantation. Transplantation 2008; 85: 386-390.
13. Schultz KR, Paquet J, Bader S, HayGlass KT. Requirement for B cells in T cell priming to minor histocompatibility antigens and development of graft-versushost disease. Bone Marrow Transplant 1995; 16: 289-295.
14. Ha YJ, Mun YC, Seong CM, Lee JR. Characterization of phenotypically distinct B-cell subsets and receptor-stimulated mitogen-activated protein kinase activation in human cord blood B cells. J Leukoc Biol 2008; 84: 1557-1564.
15. Bacigalupo A, Van Lint MT, Occhini D, Margiocco M, Ferrari G, Pittaluga PA et al. ABO compatibility and acute graft-versus-host disease following allogeneic bone marrow transplantation. Transplantation 1988; 45: 1091-1094.
16. Keever-Taylor CA, Bredeson C, Loberiza FR, Casper JT, Lawton C, Rizzo D et al. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion. Biol Blood Marrow Transplant 2001; 7: 620-630.
17. Stussi G, Seebach L, Muntwyler J, Schanz U, Gmur J, Seebach JD. Graftversus- host disease and survival after ABO-incompatible allogeneic bone marrow transplantation: a single-centre experience. Br J Haematol 2001; 113: 251-253.
18. Kimura F, Sato K, Kobayashi S, Ikeda T, Sao H, Okamoto S et al. Impact of AB0- blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program. Haematologica 2008; 93: 1686-1693.